AxoGen Interest Expense 2011-2026 | AXGN

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense AxoGen

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
167 K	-199 K	-437 K	-230 K	1.36 M	1.05 M	40 K	1.21 M	2.22 M	5.39 M	3.99 M	6.81 M	4.82 M	1.39 M	1.09 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
6.81 M	-437 K	1.91 M

Quarterly Interest Expense AxoGen

2026-Q1	2025-Q4	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
23 K	-	179 K	-37 K	-	-48 K	1 K	-107 K	-	-6 K	-277 K	16 K	-	61 K	249 K	354 K	-	417 K	565 K	444 K	-	397 K	31 K	31 K	-	-7 K	11 K	14 K	-	-16 K	544 K	586 K	-	578 K	554 K	508 K	5.39 M	5.39 M	1.16 M	5.39 M	-	1.04 M	1.02 M	995 K	-	1.38 M	1.39 M	1.19 M	-	1.21 M	1.22 M	1.07 M	-	145 K	125 K	125 K	-	318 K	406 K	203 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
5.39 M	-277 K	744 K

Interest Expense of other stocks in the Medical devices industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Allied Healthcare Products AHPI	191 K	-	3.58 %	$ 2.21 M	USA
Apollo Endosurgery APEN	4.67 M	-	-	$ 475 M	USA
Alphatec Holdings ATEC	45.9 M	$ 10.23	-0.97 %	$ 1.54 B	USA
EDAP TMS S.A. EDAP	232 K	$ 3.45	3.29 %	$ 129 M	France
Aziyo Biologics AZYO	-2.76 M	-	1.37 %	$ 20.5 M	USA
Avinger AVGR	1.72 M	-	-20.74 %	$ 369 K	USA
Axonics Modulation Technologies AXNX	-2.43 M	-	-	$ 3.31 B	USA
BioSig Technologies BSGM	1.6 M	-	37.08 %	$ 85.7 M	USA
BIOLASE BIOL	-1 K	-	-13.19 %	$ 166 K	USA
Conformis CFMS	2.02 M	-	-	$ 16.4 M	USA
ClearPoint Neuro CLPT	-146 K	$ 11.1	-0.72 %	$ 314 M	USA
Cardiovascular Systems CSII	1.63 M	-	0.15 %	$ 844 M	USA
Delcath Systems DCTH	-70 K	$ 11.53	4.63 %	$ 413 M	USA
Neovasc NVCN	133 K	-	-	$ 111 M	Canada
Dynatronics Corporation DYNT	410 K	-	14.99 %	$ 929 K	USA
Eargo EAR	549 K	-	-	$ 10.2 M	USA
Electromed ELMD	78 K	$ 25.81	0.98 %	$ 218 M	USA
Butterfly Network BFLY	-13 K	$ 4.82	-0.52 %	$ 1.02 B	USA
Second Sight Medical Products EYES	947 K	-	-0.97 %	$ 54.4 M	USA
Globus Medical GMED	3.41 M	$ 90.03	-0.63 %	$ 12.2 B	USA
Helius Medical Technologies HSDT	46.9 K	$ 2.16	-	$ 1.31 M	USA
CONMED Corporation CNMD	31.1 M	$ 36.64	2.12 %	$ 1.14 B	USA
Inspire Medical Systems INSP	-2.66 M	$ 48.25	-12.02 %	$ 1.42 B	USA
Integer Holdings Corporation ITGR	-53.2 M	$ 85.85	2.26 %	$ 2.98 B	USA
Invacare Corporation IVC	28.5 M	-	-	$ 24.7 M	USA
Edwards Lifesciences Corporation EW	7.2 M	$ 82.91	-0.5 %	$ 48.5 B	USA
OrthoPediatrics Corp. KIDS	6.05 M	$ 17.04	7.98 %	$ 400 M	USA
LivaNova PLC LIVN	664 K	$ 57.59	-2.51 %	$ 3.14 B	Britain
LENSAR LNSR	636 K	$ 5.48	-1.44 %	$ 65.5 M	USA
Pulmonx Corporation LUNG	790 K	$ 1.27	-4.51 %	$ 51.7 M	USA
MiMedx Group MDXG	-558 K	$ 3.64	0.83 %	$ 538 M	USA
Cutera CUTR	-244 K	-	-10.19 %	$ 1.99 M	USA
Myomo MYO	-668 K	$ 0.88	1.69 %	$ 36.8 M	USA
NanoVibronix NAOV	135 K	-	-	$ 1.08 M	USA
NuVasive NUVA	-21.4 M	-	-	$ 2.07 B	USA
Natus Medical Incorporated NTUS	1.87 M	-	1.94 %	$ 1.05 B	USA
Vivos Therapeutics VVOS	1.4 M	$ 0.71	-4.7 %	$ 7.29 M	USA